Cargando…

Dendrimeric Systems and Their Applications in Ocular Drug Delivery

Ophthalmic drug delivery is one of the most attractive and challenging research area for pharmaceutical scientists and ophthalmologists. Absorption of an ophthalmic drug in conventional dosage forms is seriously limited by physiological conditions. The use of nonionic or ionic biodegradable polymers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yavuz, Burçin, Bozdağ Pehlivan, Sibel, Ünlü, Nurşen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874982/ https://www.ncbi.nlm.nih.gov/pubmed/24396306 http://dx.doi.org/10.1155/2013/732340

Ejemplares similares

An Overview on Dry Eye Treatment: Approaches for Cyclosporin A Delivery
por: Yavuz, Burçin, et al.
Publicado: (2012)

Dendrimeric Nanoarchitectures Mediated Transdermal and Oral Delivery of Bioactives
por: Gajbhiye, V., et al.
Publicado: (2008)

Dendrimeric Structures in the Synthesis of Fine Chemicals
por: Bizzarri, Bruno Mattia, et al.
Publicado: (2021)

Antimicrobial Dendrimeric Peptides: Structure, Activity and New Therapeutic Applications
por: Scorciapino, Mariano A., et al.
Publicado: (2017)

Dendrimeric HIV-peptide delivery nanosystem affects lipid membranes structure
por: Milowska, Katarzyna, et al.
Publicado: (2021)

Design of dendrimeric structures to treat allergic disorders
por: Blazquez, AB, et al.
Publicado: (2013)

Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer
por: Liu, Juan, et al.
Publicado: (2021)

Effect of dendrimeric composition on the removal of pyrene from water
por: Triano, Rebecca M., et al.
Publicado: (2015)

Dendrimeric Antigens for Drug Allergy Diagnosis: A New Approach for Basophil Activation Tests
por: Molina, Noemi, et al.
Publicado: (2018)

Dendrimeric Poly(Epsilon-Lysine) Delivery Systems for the Enhanced Permeability of Flurbiprofen across the Blood-Brain Barrier in Alzheimer’s Disease
por: Al-azzawi, Shafq, et al.
Publicado: (2018)

Niosomal Drug Delivery Systems for Ocular Disease—Recent Advances and Future Prospects
por: Durak, Saliha, et al.
Publicado: (2020)

Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal
por: Gou, Sanhu, et al.
Publicado: (2021)

Short, Lipidated Dendrimeric γ-AApeptides as New Antimicrobial Peptidomimetics
por: Wang, Yafeng, et al.
Publicado: (2023)

Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications
por: Kalomiraki, Marina, et al.
Publicado: (2015)

Fluorescent BAPAD Dendrimeric Antigens Are Efficiently Internalized by Human Dendritic Cells
por: Mesa-Antunez, Pablo, et al.
Publicado: (2016)

Azithromycin novel drug delivery system for ocular application
por: Gilhotra, Ritu Mehra, et al.
Publicado: (2011)

Biomaterial Drug Delivery Systems for Prominent Ocular Diseases
por: Sapowadia, Avin, et al.
Publicado: (2023)

Emerging Nano-Formulations and Nanomedicines Applications for Ocular Drug Delivery
por: Khiev, Dawin, et al.
Publicado: (2021)

Polysaccharides in Ocular Drug Delivery
por: Dubashynskaya, Natallia, et al.
Publicado: (2019)

Dendrimeric peptides can confer protection against foot-and-mouth disease virus in cattle
por: Soria, Ivana, et al.
Publicado: (2017)

Cellulosic Polymers for Enhancing Drug Bioavailability in Ocular Drug Delivery Systems
por: Gupta, Bharti, et al.
Publicado: (2021)

Quantifying the effects of antiangiogenic and chemotherapy drug combinations on drug delivery and treatment efficacy
por: Yonucu, Sirin, et al.
Publicado: (2017)

Nanoparticle-Hydrogel Composite Drug Delivery System for Potential Ocular Applications
por: Hsu, Xuan-Ling, et al.
Publicado: (2021)

Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application
por: Tsai, Cheng-Han, et al.
Publicado: (2018)

Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases
por: Tsung, Ta-Hsin, et al.
Publicado: (2023)

Recent Advances of Ocular Drug Delivery Systems: Prominence of Ocular Implants for Chronic Eye Diseases
por: Mostafa, Mahmoud, et al.
Publicado: (2023)

Advances in Ocular Drug Delivery Systems
por: Silva-Cunha, Armando
Publicado: (2021)

Nanoparticles in Ocular Drug Delivery Systems
por: Almeida, Hugo, et al.
Publicado: (2023)

Ocular Drug Delivery for Glaucoma Management
por: Gooch, Nathan, et al.
Publicado: (2012)

Penetration Enhancers in Ocular Drug Delivery
por: Moiseev, Roman V., et al.
Publicado: (2019)

Ocular Drug Delivery: Advancements and Innovations
por: Tian, Bo, et al.
Publicado: (2022)

Hydrogel Biomaterials for Application in Ocular Drug Delivery
por: Lynch, Courtney R., et al.
Publicado: (2020)

Microneedle-based ocular drug delivery systems – recent advances and challenges
por: Gadziński, Piotr, et al.
Publicado: (2022)

Design, Synthesis and Activity of New N(1)-Alkyl Tryptophan Functionalized Dendrimeric Peptides against Glioblastoma
por: Sowińska, Marta, et al.
Publicado: (2022)

A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma
por: Peter, Maneesha, et al.
Publicado: (2021)

Updates on Biodegradable Formulations for Ocular Drug Delivery
por: Tsung, Ta-Hsin, et al.
Publicado: (2023)

Recent advances in ocular drug delivery system
por: Nagaich, Upendra
Publicado: (2014)

Microemulsion: New Insights into the Ocular Drug Delivery
por: Hegde, Rahul Rama, et al.
Publicado: (2013)

Multiepitope Dendrimeric Antigen-Silica Particle Composites as Nano-Based Platforms for Specific Recognition of IgEs
por: Gil-Ocaña, Violeta, et al.
Publicado: (2021)

Ocular Drug, Gene and Cellular Delivery Systems and Advanced Therapy Medicinal Products
por: Eldem, Türkan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_smikvlcrk6rmebfhpfnqi80mh3